Results Snapshot
Quarterly Analysis Highlights - YoY
Net Sales
YoY Growth in quarter ended Sep 2025 is -4.62% vs 3.56% in Sep 2024
Consolidate Net Profit
YoY Growth in quarter ended Sep 2025 is 58.96% vs -92.71% in Sep 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in quarter ended Sep 2025 is -89.57% vs -19.11% in Sep 2024
Interest
YoY Growth in quarter ended Sep 2025 is -11.62% vs 3.64% in Sep 2024
Operating Profit Margin (Excl OI)
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024
Compare Quarterly Results Of Yixintang Pharmaceutical Group Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -1.48% vs -12.98% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -4.62% vs 3.56% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -77.44% vs -42.54% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 58.96% vs -92.71% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -90.38% vs -15.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -89.57% vs -19.11% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is 1.55% vs -5.85% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -11.62% vs 3.64% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has fallen from Sep 2024






